KCTD15 Polyclonal Antibody-BS71138 Biopharmaceutical manufacturing EGF is initially synthesized as

EGF is initially synthesized as a 130 kDa precursor transmembrane protein containing 9 EGF units

and which has significant amino-acid sequence similarity to a Tyr/Ser-protein phosphatase encoded by the late gene H1 of vaccinia virus

RRID: AB_2839773

MELK and EED

KCTD15 Polyclonal Antibody-BS71138 Biopharmaceutical manufacturing EGF is initially synthesized asKCTD15 Polyclonal Antibody Sizes: 50 l, 100 l Catalogue Numbers: BS71138 50, BS71138 100 Product: 1mg ml in PBS with 0. 02% sodium azide, 50% glycerol, pH7. 2 Swiss Prot: Q96SI1 Host: Rabbit Reactivity: Human, Mouse, Rat Applications: WB All Applications: WB,1: 500 1: 2000 Background: During embryonic development, interferes with neural crest formation (By similarity. Inhibits AP2 transcriptional activity by interaction with its activation domain.